bioMerieux's market cap is currently ―. The company's EPS TTM is €3.028; its P/E ratio is 33.35; and it has a dividend yield of 0.85%. bioMerieux is scheduled to report earnings on September 4, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Jun 22	Dec 21	Jun 21	Dec 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 552.60M	€ 524.20M	€ 803.50M	€ 493.20M	€ 389.20M
Total Assets	€ 5.19B	€ 5.04B	€ 4.62B	€ 4.16B	€ 3.93B
Total Debt	€ 505.40M	€ 591.70M	€ 462.50M	€ 524.70M	€ 481.30M
Net Debt	€ -47.20M	€ 67.50M	€ -341.00M	€ 31.50M	€ 92.10M
Total Liabilities	-	€ 1.53B	€ 1.44B	€ 1.41B	€ 1.45B
Stockholders Equity	€ 3.60B	€ 3.47B	€ 3.12B	€ 2.70B	€ 2.43B
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in EUR

bioMerieux Earnings and Revenue History

Income Statement >

bioMerieux Debt to Assets

Balance Sheet >

bioMerieux Cash Flow

Cash Flow >

bioMerieux Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing